je.st
news
Tag: genetic
Startup in biotech adds two base pairs to genetic code and life on earth may never be the same
2015-08-24 18:16:04| Extremetech
It took evolution a billion years to devise the four-letter chemical code of DNA. Now for the first time in recorded history, organisms with a new, expanded, genetic code are taking shape in the laboratory.
Scientists discover genetic pathway responsible for aging
2015-07-29 14:28:38| Extremetech
Last week, a discovery published by scientists at Northwestern University detailed a new genetic switch that may prove to be a watershed in the fight against aging.
Tags: responsible
discover
genetic
scientists
Deep genetic sequencing reveals how wooly mammoths adapted to the Arctic
2015-07-06 15:00:24| Extremetech
A new study from the University of Chicago has done the most detailed mammoth DNA sequencing so far, revealing just how these enormous beasts managed to survive a grueling ice age.
Tags: deep
genetic
adapted
reveals
Transferring Genetic Improvement
2015-06-01 02:00:00| ThePigSite - Industry News
CANADA - The rate of genetic change in the nucleus population is the basis by which genetic improvement is measured and evaluated, writes Bob Kemp, PhD P.Ag, Vice President Genetic Programs and Research & Development, Genesus.
Tags: improvement
genetic
transferring
genetic improvement
First Study Evaluating DNA Mismatch Repair as Genetic Guide for Immunotherapy Treatment with Mercks KEYTRUDA (pembrolizumab) Presented at 2015 ASCO Annual Meeting and Published in the New England Journal of Medicine
2015-05-29 20:05:00| Merck.com - Product News
Dateline City: KENILWORTH, N.J. Early Findings Show DNA Mismatch Repair-Deficient Colorectal and Other Tumors Highly Responsive to Checkpoint Blockade with Anti-PD-1 Therapy Merck Plans to Initiate Phase 2 Registrational Study with KEYTRUDA (KEYNOTE-164) to Evaluate MMR-Deficiency in Colorectal Cancer KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced results from the first study evaluating the correlation of benefit with an immunotherapy based on DNA mismatch repair (MMR) deficiency, a well-established form of genetic instability in many cancers characterized by the loss of function of the MMR pathway. Language: English Contact: MerckMedia:Pamela Eisele, 267-664-0282Claire Mulhearn, 908-200-1889orInvestors:Joseph Romanelli, 908-740-1986Justin Holko, 908-740-1879 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Sites : [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] next »